quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:08·1085d
SECFiling
Jounce Therapeutics Inc. logo

SEC Form EFFECT filed by Jounce Therapeutics Inc.

JNCE· Jounce Therapeutics Inc.
Health Care
Original source

Companies

  • JNCE
    Jounce Therapeutics Inc.
    Health Care

Recent analyst ratings

  • May 11UpdateRobert W. Baird$7.00
  • May 6UpdateRaymond James$20.00
  • Mar 16UpdateSMBC Nikko$17.00
  • Feb 4UpdateCowen & Co.-
  • Nov 5UpdateRaymond James$15.00
  • Sep 14UpdateRaymond James$10.00

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by Jounce Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G filed by Jounce Therapeutics Inc.
  • 13D/G811d
    SEC Form SC 13G/A filed by Jounce Therapeutics Inc. (Amendment)
  • SEC1074d
    SEC Form 15-12G filed by Jounce Therapeutics Inc.
  • INSIDER1084d
    SEC Form 4 filed by Concentra Biosciences, Llc
  • INSIDER1084d
    SEC Form 4 filed by Tang Kevin C
  • INSIDER1084d
    SEC Form 3: New insider Concentra Biosciences, Llc claimed ownership of 36,367,727 shares
  • 13D/G1084d
    SEC Form SC 13D/A filed by Jounce Therapeutics Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022